February 2025 – Page 19 – Talk Bio

Actionable Insights Powered by AI

FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer

3 months ago talkbio0Tagged Approved, Biochemical Pathway, Carcinoma breast stage IV, Diagnosis, Enhertu, erbB-2 Receptor, HER2-ultralow, Pet Animal, Precision Medicine, Roche (company), United States Food and Drug Administration

Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine

Merck Suspends Gardasil Shipments to China, Lowers 2025 Revenue Forecast

3 months ago talkbio0Tagged Cancer Vaccines, China, Gardasil, Merck, shipment, Suspensions

Merck, Gardasil, China, revenue forecast, cancer vaccine, shipment suspension

CDC Orders Retraction of Research Papers and Removes Website Content Amid New Language Restrictions

3 months ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Feeling content, Gender, Languages, LGBTQ+, removal technique, research retraction, restrictions, Scientific Publication, Sense of identity (observable entity), Web Site

CDC, research retraction, website content removal, language restrictions, LGBTQ, gender identity, scientific publications

Charles River Laboratories Closing Durham Facility, Laying Off 31 Employees

3 months ago talkbio0Tagged Charles, Contract Research Organization, Durham, Facility (object), North Carolina, Pharmaceutical Research, Reparative closure, restructuring, River Laboratories

Charles River Laboratories, Durham, North Carolina, facility closure, layoffs, pharmaceutical research, contract research organization, restructuring

Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs

3 months ago talkbio0Tagged Drug Industry, Drug shortages, Health care facility, Import, Medical Devices, medical supply chain, Trump tariffs

Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes

Omega Therapeutics Faces Bankruptcy and Layoffs Despite Recent Novo Nordisk Obesity Deal

3 months ago talkbio0Tagged Bankruptcy, deal, Epigenomics, financial struggles, Flagship, Nordisk, Obesity, Pioneering

Omega Therapeutics, bankruptcy, layoffs, Novo Nordisk, obesity deal, Flagship Pioneering, epigenomics, financial struggles

FDA Approves Vertex’s Journavx: A Breakthrough Non-Opioid Pain Medication

3 months ago talkbio0Tagged acute pain treatment, Approved, Inhibitor, Journavx, Non-Opioid Pain, Suzetrigine, United States Food and Drug Administration

Journavx, suzetrigine, Vertex Pharmaceuticals, FDA approval, non-opioid pain reliever, acute pain treatment, NaV1.8 inhibitor

Sionna Therapeutics Aims for $150 Million IPO to Advance Cystic Fibrosis Treatments

3 months ago talkbio0Tagged Clinical Trials, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, IPO, Nasdaq, NBD1, Proteins, Sionna, Stabilizer - function

Sionna Therapeutics, IPO, cystic fibrosis, CFTR protein, NBD1 stabilizers, biotech, Nasdaq, clinical trials

GH Research Reports Positive Phase 2b Results for Inhaled 5-MeO-DMT in Treatment-Resistant Depression

3 months ago talkbio0Tagged Clinical Trials, GH Research, GH001, Phase 2b, psychedelic therapy, treatment-resistant depression

GH Research, 5-MeO-DMT, GH001, treatment-resistant depression, psychedelic therapy, clinical trial, Phase 2b

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

3 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures